SILVER SPRING, MD January 9, 2009 – The American Herbal Products Association (AHPA) applauds the U.S. Food and Drug Administration’s (FDA) efforts to recall and warn consumers about products marketed as dietary supplements that contain undeclared, active pharmaceutical ingredients.
FDA’s efforts align with AHPA’s mission to support the responsible commerce of dietary supplements.
Under the U.S. Food, Drug & Cosmetics Act (FDCA), products marketed as dietary supplements that contain undeclared, active pharmaceutical ingredients are illegal drugs and should be removed from the marketplace.
“We applaud this good work by FDA,” said AHPA President Michael McGuffin. “AHPA’s mission to promote the responsible commerce of herbal products can only be accomplished when FDA and other government agencies actively enforce the law against outliers.”
None of the products identified by FDA are marketed by members of AHPA or, to the best of AHPA’s knowledge, any other trade association in the dietary supplement industry.
Note to Editors: Regulations impacting herbal supplements are issued by FDA, the Federal Trade Commission, the U.S. Department of Agriculture, the U.S. Fish & Wildlife Service, the Department of Commerce and many other governing bodies at the state, federal and international level. To arrange an interview with an expert, please contact AHPA’s Director of Communications, Katia Fowler (email@example.com; 301-588-1171 x104).
The American Herbal Products Association (AHPA) is the only national trade association devoted to herbal issues. Representing the core of the botanical trade—comprised of the finest growers, processors, manufacturers and marketers of herbal products—our mission is to promote the responsible commerce of herbal products. AHPA committees generate self-regulations to ensure the highest level of quality with respect to the way herbal products are manufactured, labeled, and sold. Website: www.ahpa.org.